The blood concentration of high-sensitivity cardiac troponin T (hs-cTnT) is an established, useful biomarker for evaluating the pathogenesis of heart failure and predicting cardiovascular events.
Introduction
Type 2 diabetes mellitus is closely associated with lifestyle and is an important risk factor for cardiovascular disease worldwide. However, the importance of type 2 diabetes mellitus as a risk factor for cardiovascular disease is not always explained by high blood glucose levels alone. Other classical cardiovascular risk factors, such as hypertension, dyslipidemia, and smoking habits, also affect the progression of atherosclerosis or the occurrence of cardiovascular events 1, 2 . The significance of novel risk factors for cardiovascular disease, such as insulin resistance, inflammation, oxidative stress, advanced glycation end products (AGEs), and arterial dysfunction, in type 2 diabetes mellitus have recently been noted 3 5 .
The blood concentration of cardiac troponin T (cTnT), a component of the troponin complex, is used clinically as a diagnostic marker for acute coronary syndrome because cTnT is rapidly released from the myocardium into the bloodstream following myocardial damage 6 . Furthermore, several clinical and epidemiological studies have demonstrated that the blood concentration of cTnT, i.e., high-sensitivity cTnT (hs-cTnT), measured with a highly sensitive assay, represents a useful biomarker for evaluating the pathogenesis of heart failure or predicting cardiovascular events 7, 8 . A close relationship between diabetes mellitus and hs-cTnT elevation has been reported in the general population 9 . However, factors that are important for elevating hs-cTnT in patients with type 2 diabetes mellitus are little known. Therefore, the present study was performed to clarify specific patient factors, including novel risk factors for cardiovascular disease, that affect hs-cTnT elevation in patients with type 2 diabetes mellitus as related to primary cardiovascular events.
Materials and Methods

Study Population
This study was conducted at the Hitsumoto Medical years. All participants provided informed consent, and the study protocol was approved by the Local Ethics Committee of the Hitsumoto Medical Clinic. Groningen, The Netherlands), as previously described 10, 11 .
Estimation of Cardiovascular Risk Factors
Briefly, autofluorescence was defined as the average light intensity per nanometer in the range of 300 to 420 nm.
Autofluorescence levels were expressed in arbitrary units Used as a marker of arterial function was the augmentation index (AIx) measured at the radial artery. The radial AIx was measured with an applanation tonometrybased device (HEM-9010AI; Omron Healthcare Co., Ltd., Kyoto, Japan) and the subject in a sitting position. This technique has been described in detail in previous studies 12 . Briefly, the tonometry sensor unit consists of a pressure sensor composed of an array of 40 microtransducer elements. When the unit is placed on a patient's wrist, 1 of the 40 sensor elements is automatically selected to obtain optimal radial pressure waveforms. The first and second systolic peaks are automatically detected and, consequently, the radial AIx is calculated. The validity and reliability of the radial AIx as measured with this method are well established, with several studies reporting a close linear correlation between the radial AIx and the central AIx 12 . In addition, right brachial blood pressure was automatically measured twice with the oscillometric method. The average of 2 readings was used to determine the systolic and diastolic blood pressures.
Blood Sampling
Blood samples were collected from the antecubital vein in the morning after the patient had fasted for 12 hours. 17 . In the hs-cTnT assay, the lower limit of detection was 0.003 ng/mL. to be statistically significant.
Results
The hs-cTnT was detected in 244 (87.1%) patients ( Table 2) .
Multiple regression analysis was performed with explanatory variables with p<0.10 in univariate analysis.
From the analysis, radial AIx, skin autofluorescence, d- Table 1 ROMs test, and BNP were selected as independent variables when hs-cTnT was a subordinate factor ( Table 3 ).
Discussion
Otsuka et al. 18 reported that the prevalence of detectable elevation of hs-cTnT in a healthy population was 80.9% at a cut-off level of 0.002 ng/mL and 67.7% at a cut-off level of 0.003 ng/mL. The results of this study indicated that up to 87.1% of the population was detected with an elevation of hs-cTnT at a cut-off level of 0.003 ng/mL. Although the mean age of the population in the present study was higher than that in the study by Otsuka In basic studies, high blood glucose concentrations have been reported to cause myocardial damage via dysfunction of the microcirculation, increased oxidative stress, or other pathways 19, 20 . In clinical studies, furthermore, relationships among markers of blood glucose concentrations and cTnT blood concentrations have been reported 21, 22 . Zheng et al. 21 reported that fasting blood glucose level was an independent predictor of blood hs-cTnT in an overt cardiovascular disease-free communitybased study. Selvin et al. 22 also reported a significant relationship between hs-cTnT elevation and HbA1c levels. In the present study, however, fasting blood glucose levels showed no statistically significant relationship with hs-cTnT. The HbA1c levels also showed no significant relationships with hs-cTnT by multivariate analysis, even though the result from single regression analysis was significant. On the other hand, skin autofluorescence level as a marker of AGE in vivo was an independent factor related to hs-cTnT elevation as a subordinate factor. Basic studies report several pathways by which AGE could influence diabetic cardiomyopathy or cardiac remodeling 23, 24 , and results of the present study also indicated the importance of AGE to clinical myocardial damage. Yamagishi et al. reported that AGE is a marker that is compatible with the theory of "hyperglycemic memory" 25 .
Therefore, we should be intervening at an early stage of blood glucose elevation and adequately controlling blood glucose levels over the long term to prevent the progression of myocardial damage in patients with type 2 diabetes mellitus. Insulin resistance has been considered to have an important role in the pathogenesis of type 2 diabetes mellitus. Furthermore, some clinical studies have reported a correlation between insulin resistance and myocardial damage 26, 27 . In the present study, however, HOMA-IR as a marker of insulin resistance was not significantly correlated with hs-cTnT. The HOMA-IR has limitations as a marker of insulin resistance, especially in patients with high blood glucose levels 28 The AIx communicates arterial wave reflection 12 , and some clinical studies have reported that AIx is elevated with an increase in arterial wall stiffness 34 . In recent years, several studies have indicated the importance of left ventricular dysfunction in heart failure or the progression of myocardial damage; furthermore, increases in aortic artery stiffness are known to cause left ventricular dysfunction 35 . Therefore, the relationship between hs-cTnT and radial AIx identified in this study was considered to reflect myocardial damage via left ventricular dysfunction resulting from an increase in vascular resistance or afterload. Endothelial dysfunction is one of the crucial factors in the development of heart failure, and some clinical studies have reported that AIx is indicative of endothelial dysfunction 36, 37 . Endothelial dysfunction has also been known to cause left ventricular dysfunction or myocardial damage 38, 39 ; therefore, the significant correlation of hs-cTnT with radial AIx in patients with type 2 diabetes mellitus may be partly explained by the pres- In conclusion, the study findings indicate that novel cardiovascular risk factors including AGE, in vivo oxidative stress, and high arterial reflection are closely associated with high concentrations of blood hs-cTnT in patients with type 2 diabetes mellitus. important contributions.
